Literature DB >> 17145626

Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.

Jen-Fen Fu1, Der-Cherng Liang, Lee-Yung Shih.   

Abstract

t(11;19)(q23;p13.3); is one of the common chromosomal translocations in acute leukemias involving MLL rearrangements. This translocation generates MLL/ENL fusion transcripts. In a study of acute leukemias, 148 patients were identified to have MLL rearrangements by Southern blot analysis. Reverse transcriptase-polymerase chain reaction (RT-PCR) assay, using primer sets covering the 2 previously described breakpoints at exons 2 and 7 of ENL detected 11 samples harboring MLL/ENL. complementary DNA panhandle PCR further identified 4 additional cases with novel breakpoints in ENL at exon 4 or 6. Sequencing analysis showed that all novel fusion transcripts were in-frame. The conventional cytogenetic analysis failed to detect t(11;19) in 6 of 13 cases. Of 15 patients with MLL/ENL, 7 had precursor B-cell acute lymphoblastic leukemia, 4 had T-cell acute lymphoblastic leukemia, and 4 had acute myeloid leukemia. The present study showed that PCR-based techniques are more sensitive than conventional karyotyping for detecting MLL/ENL fusions and an extra antisense primer at exon 6 of ENL should be included in RT-PCR assay to ensure complete detection of all MLL/ENL fusion transcripts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17145626     DOI: 10.1309/XKQLMPN81LGG3HDL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.

Authors:  Corina Buechele; Erin H Breese; Dominik Schneidawind; Chiou-Hong Lin; Johan Jeong; Jesus Duque-Afonso; Stephen H K Wong; Kevin S Smith; Robert S Negrin; Matthew Porteus; Michael L Cleary
Journal:  Blood       Date:  2015-08-26       Impact factor: 22.113

2.  A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement.

Authors:  Byong-Joon Yoo; Myung-Hyun Nam; Hwa-Jung Sung; Chae-Seung Lim; Chang-Kyu Lee; Yun-Jung Cho; Kap-No Lee; Soo-Young Yoon
Journal:  Korean J Lab Med       Date:  2011-01

Review 3.  Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia.

Authors:  A Mummery; A Narendran; K-Y Lee
Journal:  Curr Cancer Drug Targets       Date:  2011-09       Impact factor: 3.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.